Figure 1, Panel A: Percentage of local adverse events experienced by subjects according to the number of vaccinations received and group assignment.
Groups: A. 2×10^7 SC IMVAMUNE/IMVAMUNE/Dryvax
B. 5×10^7 SC IMVAMUNE/IMVAMUNE/Dryvax
C. 1×10^8 SC IMVAMUNE/IMVAMUNE/Dryvax
D. SC Placebo/Placebo/Dryvax
E. 1×10^8 SC IMVAMUNE/IMVAMUNE/Placebo
F. 1×10^8 IM IMVAMUNE/IMVAMUNE/Dryvax
Figure 1, Panel B: Percentage of systemic adverse events experienced by subjects according to the number of vaccinations received and group assignment.
Groups: A. 2×10^7 SC IMVAMUNE/IMVAMUNE/Dryvax
B. 5×10^7 SC IMVAMUNE/IMVAMUNE/Dryvax
C. 1×10^8 SC IMVAMUNE/IMVAMUNE/Dryvax
D. SC Placebo/Placebo/Dryvax
E. 1×10^8 SC IMVAMUNE/IMVAMUNE/Placebo
F. 1×10^8 IM IMVAMUNE/IMVAMUNE/Dryvax